---
layout: default
nav_exclude: true
title: Ofatumumab
---

# Ofatumumab

**Generic Name:** Ofatumumab

**Usage:** Ofatumumab is a monoclonal antibody used to treat several types of B-cell cancers.  Specifically, its approved uses include:

* **Chronic Lymphocytic Leukemia (CLL):**  It's used in patients with previously treated CLL who have not responded well to other therapies (refractory CLL) or who have relapsed after treatment.
* **Small Lymphocytic Lymphoma (SLL):**  Treatment is similar to its use in CLL.
* **Autoimmune diseases (off-label):** While not FDA-approved for these conditions, it's sometimes used off-label to treat certain autoimmune disorders like multiple sclerosis (MS) and rheumatoid arthritis (RA) due to its B-cell depletion capabilities.  **This is crucial to emphasize - use only under strict medical supervision.**

**Side Effects:**  Ofatumumab, like other monoclonal antibodies, can cause various side effects, some mild and others serious. Common side effects include:

* **Infusion-related reactions:** Fever, chills, nausea, vomiting, rash, itching, shortness of breath.  These are often managed with pre-medication.
* **Infections:** Increased risk of infections, including serious ones, due to the depletion of B cells.
* **Low blood counts:** Anemia (low red blood cells), neutropenia (low neutrophils, a type of white blood cell), and thrombocytopenia (low platelets).
* **Gastrointestinal issues:** Diarrhea, constipation, abdominal pain.
* **Fatigue:** Feeling tired or weak.
* **Skin reactions:** Rash, itching.
* **Hepatotoxicity:** Liver damage (rare but serious).
* **Progressive Multifocal Leukoencephalopathy (PML):** A rare but potentially fatal brain infection (more common in patients with prior exposure to other immunosuppressants).


**How it Works:** Ofatumumab is a type of monoclonal antibody that targets a specific protein called CD20 found on the surface of B lymphocytes (B cells).  By binding to CD20, ofatumumab triggers several mechanisms that lead to the destruction of B cells. This helps to reduce the number of cancerous B cells in the body or, in the case of autoimmune disease, reduces the activity of the misbehaving B cells contributing to the autoimmune response. The exact mechanisms of action include complement-dependent cytotoxicity (CDC), antibody-dependent cell-mediated cytotoxicity (ADCC), and apoptosis (programmed cell death).


**FAQs:**

* **Is Ofatumumab chemotherapy?** No, it's a targeted therapy, a type of biologic agent, not a traditional chemotherapy drug.
* **How is Ofatumumab administered?** It's usually given intravenously (IV) as an infusion over a period of time.
* **How long does treatment last?** The duration of treatment depends on the patient's response and the specific disease being treated.
* **What are the long-term effects of Ofatumumab?** Long-term effects can include an increased risk of infections and other immune-related complications. Regular monitoring is necessary.
* **Can I take other medications with Ofatumumab?**  It's crucial to discuss all medications, including over-the-counter drugs and supplements, with your doctor before starting Ofatumumab.  Interactions can occur.
* **Is Ofatumumab right for me?** Only your doctor can determine if Ofatumumab is appropriate based on your specific medical condition and overall health.


**Disclaimer:** This information is for educational purposes only and should not be considered medical advice.  Always consult with your doctor or other qualified healthcare professional for any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen.  The side effects listed are not exhaustive, and individual experiences may vary.


**Note:** This information is AI-generated or crowd-sourced and may not be accurate. Please consult a medical professional for verified advice.